Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.95
- Piotroski Score 5.00
- Grade Neutral
- Symbol (AMED)
- Company Amedisys, Inc.
- Price $95.20
- Changes Percentage (-0.3%)
- Change -$0.29
- Day Low $95.20
- Day High $95.96
- Year High $98.95
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/29/2024
- Fiscal Year End N/A
- Average Stock Price Target $162.50
- High Stock Price Target $190.00
- Low Stock Price Target $85.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.64
- Trailing P/E Ratio -143.36
- Forward P/E Ratio -143.36
- P/E Growth -143.36
- Net Income $-9,747,000
Income Statement
Quarterly
Annual
Latest News of AMED
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Boot Barn CEO Jim Conroy Steps Down for Top Job at Ross, John Hazen Named Interim CEO
Boot Barn's CEO Jim Conroy is stepping down to join Ross Stores, with John Hazen taking over as interim CEO. Peter Starrett becomes executive chairman. Conroy expressed gratitude and confidence in Haz...
By Yahoo! Finance | 1 day ago -
Tough Rescue Kitty Named Rocky Becomes a Viral Inspiration After Almost Getting Euthanized 5 Years Ago (Exclusive)
Five years ago, Dawn Firestone rescued a paralyzed kitten named Rocky, determined to give him the best life despite his condition. She documented his journey on social media, raising awareness about s...
By PEOPLE.com | 1 day ago -
Evri named UK's worst delivery company as four in 10 have problems
Evri, previously known as Hermes, has been ranked as the worst parcel delivery company in the UK for the second year in a row. Around half of its customers reported issues such as delays and misplaced...
By Yahoo! Finance | 1 day ago
